Skip To Main Content
Anne-Marie Baird on Muck Rack

Anne-Marie Baird

As seen in: Nature, BMJ Open, MDPI, The Lancet, European Respiratory Journal, Future Medicine, Lung Cancer
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Anne-Marie

Contact Anne-Marie, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Prevalence of BRCA1/2 variants in an Ovarian Cancer Cohort: outcomes from a Nationwide Testing Program

|
By Ciara S. McNevin, Kate Murphy Verified, Pierre Murchan, Orla Fitzpatrick, Sharon O’Toole, Paul Smyth, Emer Atkinson, Anne-Marie Baird, Steven Gray, Cathal Ó’Brien, Trudi McDevitt, Brendan Doyle, Niamh Coleman, Stephen Finn, Karen A Cadoo, Andrea Hennessy, Georgia Thodi, Roshni Deepa Kalachand
| Nature Verified
Abstract Poly(ADP-ribose) polymerase inhibitors (PARPi) have revolutionized the management of BRCA1- and BRCA2-associated ovarian cancer (OC). In 2020, Ireland implemented a nationwide, oncology-led pathway for mainstreamed BRCA1/2 testing in patients with OC. This study evaluated the pathway and characterised the BRCA1/2 landscape in an Irish cohort of patients with OC. Samples collected between January 2020 and December 2023 were tested in two national molecular diagnostic laboratories.
Open in Who Shared Issue with article?

Surrogate Biomarker Prediction from Whole-Slide Images for Evaluating Overall Survival in Lung Adenocarcinoma

|
By Pierre Murchan, Anne-Marie Baird, Pilib O Broin, Orla Sheils
| MDPI
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Open in Who Shared View Duplicates (234) Issue with article?

The Lung Microbiome in COPD and Lung Cancer: Exploring the Potential of Metal-Based Drugs

|
By Megan O’Shaughnessy, Orla Sheils, Anne-Marie Baird
| MDPI
Abstract : Chronic obstructive pulmonary disease (COPD) and lung cancer 17 are two of the most prevalent and debilitating respiratory diseases worldwide, both associated with high morbidity and mortality rates. As major global health concerns, they impose a substantial burden on patients, healthcare systems, and society at large.
Open in Who Shared Issue with article?
See all 9 articles